Abstract:
According to modern researchers, one of the most common comorbid conditions in patients with psoriatic arthritis (PsA) is arterial hypertension (AH). The incidence of AH in PsA can reach up to 78%. In gen-eral, it has been established that AH has a special place in patients with PsA because it is an objectively traceable marker of cardiovascular pathology (CVP) in PsA in real clinical practice.
